Paper39254403
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.
Agosti V and 1 other. Asian J Androl, 2024. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects. Papers, record 39254403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39254403
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Neoplasm Grading | Major topic |
| Humans | |
| Male | |
| Prognosis | |
| Observer Variation | |
| Prostate | |
| Reproducibility of Results |
Source PubMed
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31100224 | Features and Prognostic Significance of Intraductal Carcinoma of the Prostate. | Eur Urol Oncol | 2018 | https://conductscience.org/library/papers/31100224 | PubMed |
| 2 | 26099009 | Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. | Am J Surg Pathol | 2015 | https://conductscience.org/library/papers/26099009 | PubMed |
| 3 | 33132109 | Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives. | Eur Urol Focus | 2021 | https://conductscience.org/library/papers/33132109 | PubMed |
| 4 | 23464824 | Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. | BJU Int | 2013 | https://conductscience.org/library/papers/23464824 | PubMed |
| 5 | 32759979 | Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. | Mod Pathol | 2021 | https://conductscience.org/library/papers/32759979 | PubMed |
| 6 | 36008255 | Sensitivity of multiparametric MRI and targeted biopsy for detection of adverse pathologies (Cribriform gleason pattern 4 and intraductal carcinoma): Correlation of detected and missed prostate cancer foci with whole mount histopathology. | Urol Oncol | 2022 | https://conductscience.org/library/papers/36008255 | PubMed |
| 7 | 31926805 | Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/31926805 | PubMed |
| 8 | 25154392 | Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis. | Eur Urol | 2015 | https://conductscience.org/library/papers/25154392 | PubMed |
| 9 | 31926806 | Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study. | Lancet Oncol | 2020 | https://conductscience.org/library/papers/31926806 | PubMed |
| 10 | 11172298 | Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists. | Hum Pathol | 2001 | https://conductscience.org/library/papers/11172298 | PubMed |
| 11 | 30195846 | Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups. | J Urol | 2019 | https://conductscience.org/library/papers/30195846 | PubMed |
| 12 | 28530220 | Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer. | Mod Pathol | 2017 | https://conductscience.org/library/papers/28530220 | PubMed |
| 13 | 28715578 | Adverse Pathologic Findings for Men Electing Immediate Radical Prostatectomy: Defining a Favorable Intermediate-Risk Group. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/28715578 | PubMed |
| 14 | 25189638 | Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. | Mod Pathol | 2015 | https://conductscience.org/library/papers/25189638 | PubMed |
| 15 | 32358793 | Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies. | Histopathology | 2020 | https://conductscience.org/library/papers/32358793 | PubMed |
| 16 | 36344176 | Prostate Cancer: Update on Grading and Reporting. | Surg Pathol Clin | 2022 | https://conductscience.org/library/papers/36344176 | PubMed |
| 17 | 27212078 | Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis. | Sci Rep | 2016 | https://conductscience.org/library/papers/27212078 | PubMed |
| 18 | 32459716 | The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. | Am J Surg Pathol | 2020 | https://conductscience.org/library/papers/32459716 | PubMed |
| 19 | 26743470 | The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation. | Mod Pathol | 2016 | https://conductscience.org/library/papers/26743470 | PubMed |
| 20 | 32402150 | The utility of artificial intelligence in the assessment of prostate pathology. | Histopathology | 2020 | https://conductscience.org/library/papers/32402150 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787368 | Whole-mount histopathology as spatial ground truth for artificial intelligence in prostate cancer: a structured narrative review of techniques, models, and translational gaps. | Am J Clin Exp Urol | 2026 | https://conductscience.org/library/papers/42787368 | PubMed |
| 42724578 | Incremental value of prostate-specific antigen density beyond PI-RADS and conventional MRI features for predicting the highest ISUP grade group in patients with prostate cancer diagnosed at initial systematic prostate biopsy. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42724578 | PubMed |
| 42588694 | PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588694 | PubMed |
| 42582183 | Artificial intelligence in prostate biopsy: diagnostic applications, risk stratification, and precision oncology. | Front Oncol | 2026 | https://conductscience.org/library/papers/42582183 | PubMed |
| 42474973 | Raman spectroscopic signatures of prostate cancer progression: correlation with gleason score. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42474973 | PubMed |
| 42466917 | Bias and Fairness Across the Healthcare AI Lifecycle: A Clinician-Oriented Review. | Balkan Med J | 2026 | https://conductscience.org/library/papers/42466917 | PubMed |
| 42449601 | Time-Dependent Diffusion MRI-Based Microstructural Mapping for Characterization of Cribriform and Intraductal Carcinoma Morphologies in Prostate Cancer: A Preliminary Study. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42449601 | PubMed |
| 41783818 | Impact of prognostic nutritional index and geriatric nutritional risk index on prognosis in elderly patients with early-stage prostate cancer. | Front Nutr | 2026 | https://conductscience.org/library/papers/41783818 | PubMed |
| 41659707 | Fractal dimensions for tumour-related cell types of prostate cancer on histopathology images using multiple-threshold box counting algorithm. | Biophys Physicobiol | 2025 | https://conductscience.org/library/papers/41659707 | PubMed |
| 41363115 | Methylation-based signature to distinguish indolent and aggressive prostate cancer. | Biol Open | 2025 | https://conductscience.org/library/papers/41363115 | PubMed |
| 41282577 | LncRNA expression in prostate cancer: From in silico analysis to urinary EV-based liquid biopsy for prognosis. | Noncoding RNA Res | 2026 | https://conductscience.org/library/papers/41282577 | PubMed |
| 41063546 | Cribriform pattern and IDC-P in prostate biopsies: prognostic relevance and reporting in metastatic disease. | J Pathol Clin Res | 2025 | https://conductscience.org/library/papers/41063546 | PubMed |
| 40843333 | Assessment of interobserver variability in Gleason grading for prostate carcinoma. | North Clin Istanb | 2025 | https://conductscience.org/library/papers/40843333 | PubMed |
| 40687419 | Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications. | Front Oncol | 2025 | https://conductscience.org/library/papers/40687419 | PubMed |
| 40452312 | Intraductal carcinoma of the prostate: A comprehensive literature review focused on grading challenges and controversies. | Histol Histopathol | 2025 | https://conductscience.org/library/papers/40452312 | PubMed |
| 39422628 | The continued pursuit of new strategies and new technologies. | Asian J Androl | 2024 | https://conductscience.org/library/papers/39422628 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39254403
GET https://conductscience.org/api/papers/v1/39254403/references?page=2